BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Feb. 17, 2006
View Archived Issues
Tysabri Events For Biogen Idec Overshadow Year-End Figures
Despite a rocky year that began with the Tysabri market withdrawal, Biogen Idec Inc. reported strong fourth-quarter and full-year 2005 earnings driven by robust Avonex sales and lower expenses. (BioWorld Today)
Read More
Onyx, Bayer Move Nexavar Into Yet Another Phase III
Read More
QLT’s BPH Drug Fails To Show Efficacy In Phase II
Read More
Pandemic, Defense VC Fund: $200M For Fighting Avian Flu
Read More
Holiday Notice
Read More
Clinic Roundup
Read More
Other News To Note
Read More
Appointments And Advancements
Read More